English

JONES PHARMA INC

EDGAR

Quarterly report (10-Q) · filed 2000-08-14

25 filing records in this dataset, filed from 1995-05-12 to 2000-08-14. Explore the available filing history and original sources.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

51.6 million USD

2000-06-30 · USD

Exact inputs and evidence

Revenue: 51632000 USD Source

Operating margin

60.43%

2000-06-30 · %

Exact inputs and evidence

Operating Income: 31201000 USD Source
Revenue: 51632000 USD Source

Operating cash flow

19.6 million USD

2000-06-30 · USD

Exact inputs and evidence

Operating Cash Flow: 47017000 USD Source
Operating Cash Flow: 27423000 USD Source

Free cash flow

18.4 million USD

2000-06-30 · USD

Exact inputs and evidence

Operating Cash Flow: 47017000 USD Source
Operating Cash Flow: 27423000 USD Source
Capital Expenditure: 4294000 USD Source
Capital Expenditure: 3135000 USD Source

Cash and cash equivalents: 162 million USD 1999-09-30 Source
Exact value

161558000 USD
Long-term debt including current maturities: Not available
Shares outstanding: Not available

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Net income

66.9 million USD

1999-07-01 – 2000-06-30

Exact inputs and evidence

Net income: 12547000 USD · 1999-07-01 – 1999-09-30 Source
Net income: 48944000 USD · 1999-01-01 – 1999-12-31 Source
Net income: 33910000 USD · 1999-01-01 – 1999-09-30 Source
Net income: 19172000 USD · 2000-01-01 – 2000-03-31 Source
Net income: 20137000 USD · 2000-04-01 – 2000-06-30 Source

Operating cash flow

76.9 million USD

1999-07-01 – 2000-06-30

Exact inputs and evidence

Operating cash flow: 42687000 USD · 1999-01-01 – 1999-09-30 Source
Operating cash flow: 28186000 USD · 1999-01-01 – 1999-06-30 Source
Operating cash flow: 58097000 USD · 1999-01-01 – 1999-12-31 Source
Operating cash flow: 42687000 USD · 1999-01-01 – 1999-09-30 Source
Operating cash flow: 27423000 USD · 2000-01-01 – 2000-03-31 Source
Operating cash flow: 47017000 USD · 2000-01-01 – 2000-06-30 Source
Operating cash flow: 27423000 USD · 2000-01-01 – 2000-03-31 Source

Capital expenditure

7.24 million USD

1999-07-01 – 2000-06-30

Exact inputs and evidence

Capital expenditure: 1605000 USD · 1999-01-01 – 1999-09-30 Source
Capital expenditure: 1102000 USD · 1999-01-01 – 1999-06-30 Source
Capital expenditure: 4049000 USD · 1999-01-01 – 1999-12-31 Source
Capital expenditure: 1605000 USD · 1999-01-01 – 1999-09-30 Source
Capital expenditure: 3135000 USD · 2000-01-01 – 2000-03-31 Source
Capital expenditure: 4294000 USD · 2000-01-01 – 2000-06-30 Source
Capital expenditure: 3135000 USD · 2000-01-01 – 2000-03-31 Source

Free cash flow

69.7 million USD

1999-07-01 – 2000-06-30

Exact inputs and evidence

Operating cash flow: 42687000 USD · 1999-01-01 – 1999-09-30 Source
Operating cash flow: 28186000 USD · 1999-01-01 – 1999-06-30 Source
Operating cash flow: 58097000 USD · 1999-01-01 – 1999-12-31 Source
Operating cash flow: 42687000 USD · 1999-01-01 – 1999-09-30 Source
Operating cash flow: 27423000 USD · 2000-01-01 – 2000-03-31 Source
Operating cash flow: 47017000 USD · 2000-01-01 – 2000-06-30 Source
Operating cash flow: 27423000 USD · 2000-01-01 – 2000-03-31 Source
Capital expenditure: 1605000 USD · 1999-01-01 – 1999-09-30 Source
Capital expenditure: 1102000 USD · 1999-01-01 – 1999-06-30 Source
Capital expenditure: 4049000 USD · 1999-01-01 – 1999-12-31 Source
Capital expenditure: 1605000 USD · 1999-01-01 – 1999-09-30 Source
Capital expenditure: 3135000 USD · 2000-01-01 – 2000-03-31 Source
Capital expenditure: 4294000 USD · 2000-01-01 – 2000-06-30 Source
Capital expenditure: 3135000 USD · 2000-01-01 – 2000-03-31 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2000-08-14.

Financial data available through: 1999-12-31.

Coverage by financial measure

Revenue: 4 of 11 periods available· newest 1996-12-31
Operating income: 7 of 11 periods available· newest 1999-12-31
Net income: 7 of 11 periods available· newest 1999-12-31
Operating cash flow: 7 of 11 periods available· newest 1999-12-31
Capital expenditure: 7 of 11 periods available· newest 1999-12-31
Total assets: 7 of 11 periods available· newest 1999-12-31
liabilities: No compatible figures in this window
Current assets: 7 of 11 periods available· newest 1999-12-31
Current liabilities: 7 of 11 periods available· newest 1999-12-31
Cash and cash equivalents: 6 of 11 periods available· newest 1998-12-31
long term debt: No compatible figures in this window
shares outstanding: No compatible figures in this window

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Net income
+15.6%

Prior period

USD 42.34 million

1998-01-01 – 1998-12-31
Current period

USD 48.94 million

1999-01-01 – 1999-12-31

Exact inputs and evidence

48944000 − 42335000 = 6609000 USD

42335000 USD · 1998-01-01 – 1998-12-31
Inspect prior input Prior source
48944000 USD · 1999-01-01 – 1999-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · JONES PHARMA INC · 1999-12-31 JONES PHARMA INC (edgar:793613) Year-over-year change in Net income: 6609000 USD Concept: fundies:NetIncome Period: 1999-01-01 to 1999-12-31 Values: Latest reported Published: 2026-11-02T23:23:14Z Snapshot: ca0e640291d283e31cd085dc5f031d4808aa3fcec275282fa6d28a8b9cdc6dad Dimensions: Consolidated View: https://fundies.io/companies/edgar/793613?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: 48944000 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/793613/0000950124-00-001305.txt#2913 Input fundies:NetIncome: 42335000 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/793613/0000950124-00-001305.txt#2913
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
+164.8%

Prior period

USD 21.94 million

1998-01-01 – 1998-12-31
Current period

USD 58.1 million

1999-01-01 – 1999-12-31

Exact inputs and evidence

58097000 − 21942000 = 36155000 USD

21942000 USD · 1998-01-01 – 1998-12-31
Inspect prior input Prior source
58097000 USD · 1999-01-01 – 1999-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · JONES PHARMA INC · 1999-12-31 JONES PHARMA INC (edgar:793613) Year-over-year change in Operating cash flow: 36155000 USD Concept: fundies:OperatingCashFlow Period: 1999-01-01 to 1999-12-31 Values: Latest reported Published: 2026-11-02T23:23:14Z Snapshot: ca0e640291d283e31cd085dc5f031d4808aa3fcec275282fa6d28a8b9cdc6dad Dimensions: Consolidated View: https://fundies.io/companies/edgar/793613?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: 58097000 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/793613/0000950124-00-001305.txt#2934 Input fundies:OperatingCashFlow: 21942000 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/793613/0000950124-00-001305.txt#2934
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
+73.6%

Prior period

USD 2.33 million

1998-01-01 – 1998-12-31
Current period

USD 4.05 million

1999-01-01 – 1999-12-31

Exact inputs and evidence

4049000 − 2333000 = 1716000 USD

2333000 USD · 1998-01-01 – 1998-12-31
Inspect prior input Prior source
4049000 USD · 1999-01-01 – 1999-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · JONES PHARMA INC · 1999-12-31 JONES PHARMA INC (edgar:793613) Year-over-year change in Capital expenditure: 1716000 USD Concept: fundies:CapitalExpenditure Period: 1999-01-01 to 1999-12-31 Values: Latest reported Published: 2026-11-02T23:23:14Z Snapshot: ca0e640291d283e31cd085dc5f031d4808aa3fcec275282fa6d28a8b9cdc6dad Dimensions: Consolidated View: https://fundies.io/companies/edgar/793613?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 4049000 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/793613/0000950124-00-001305.txt#2938 Input fundies:CapitalExpenditure: 2333000 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/793613/0000950124-00-001305.txt#2938
The citation records this snapshot. The page link may show a newer release later.

Comparable inputs unavailable for: Revenue.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

1996 1996-01-01 – 1996-12-31

Revenue USD 100.15 million 100% of revenue
Cost of revenue USD 20.28 million 20% of revenue
Operating expenses USD 26.32 million 26% of revenue
Other operating costs Derived USD 35.56 million 36% of revenue
Operating income USD 18 million 18% of revenue
Tax, interest and other Derived −USD 144,000 −0.1% of revenue
Net income USD 18.14 million 18% of revenue

Cash

Operating cash flow USD 20.67 million 21% of revenue
Capital expenditure USD 7.39 million 7.4% of revenue
Free cash flow Derived USD 13.28 million 13% of revenue

Share of revenue by period

Net income
Tax, interest and other
Operating costs

1993 15%77%
1994 12%80%
1995 Net income was higher than operating income, so the split is not drawn.
1996 Net income was higher than operating income, so the split is not drawn.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
1993 1993-01-01 – 1993-12-31	43215498	33223588 Derived	9991910	3580997 Derived	6410913	-3855593 Derived	Source 1993-01-01 – 1993-12-31: 43215498 USD Inspect Revenue Open source 1993-01-01 – 1993-12-31: 9991910 USD Inspect Operating Income Open source 1993-01-01 – 1993-12-31: 6410913 USD Inspect Net Income Open source 1993-01-01 – 1993-12-31: 1090658 USD Inspect Operating Cash Flow Open source 1993-01-01 – 1993-12-31: 4946251 USD Inspect Capital Expenditure Open source
1994 1994-01-01 – 1994-12-31	62153975	49787711 Derived	12366264	4846366 Derived	7519898	8520466 Derived	Source 1994-01-01 – 1994-12-31: 62153975 USD Inspect Revenue Open source 1994-01-01 – 1994-12-31: 12366264 USD Inspect Operating Income Open source 1994-01-01 – 1994-12-31: 7519898 USD Inspect Net Income Open source 1994-01-01 – 1994-12-31: 12208788 USD Inspect Operating Cash Flow Open source 1994-01-01 – 1994-12-31: 3688322 USD Inspect Capital Expenditure Open source
1995 1995-01-01 – 1995-12-31	74791815	65919815 Derived	8872000	-3517000 Derived	12389000	4856000 Derived	Source 1995-01-01 – 1995-12-31: 74791815 USD Inspect Revenue Open source 1995-01-01 – 1995-12-31: 8872000 USD Inspect Operating Income Open source 1995-01-01 – 1995-12-31: 12389000 USD Inspect Net Income Open source 1995-01-01 – 1995-12-31: 10304000 USD Inspect Operating Cash Flow Open source 1995-01-01 – 1995-12-31: 5448000 USD Inspect Capital Expenditure Open source
1996 1996-01-01 – 1996-12-31	100153086	82158086 Derived	17995000	-144000 Derived	18139000	13281000 Derived	Source 1996-01-01 – 1996-12-31: 100153086 USD Inspect Revenue Open source 1996-01-01 – 1996-12-31: 17995000 USD Inspect Operating Income Open source 1996-01-01 – 1996-12-31: 18139000 USD Inspect Net Income Open source 1996-01-01 – 1996-12-31: 20667000 USD Inspect Operating Cash Flow Open source 1996-01-01 – 1996-12-31: 7386000 USD Inspect Capital Expenditure Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 100.2M 1996

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
19931993-12-31	Revenue	43215498	Revenue: 43215498 Open source
19941994-12-31	Revenue	62153975	Revenue: 62153975 Open source
19951995-12-31	Revenue	74791815	Revenue: 74791815 Open source
19961996-12-31	Revenue	100153086	Revenue: 100153086 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

33.9% 1996

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
19931993-12-31	Year over year	No prior comparable period	Revenue: 43215498 Open source
19941994-12-31	Year over year	43.8%	Revenue: 62153975 Open source Revenue: 43215498 Open source
19951995-12-31	Year over year	20.3%	Revenue: 74791815 Open source Revenue: 62153975 Open source
19961996-12-31	Year over year	33.9%	Revenue: 100153086 Open source Revenue: 74791815 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin 18% 1996

Net margin 18.1% 1996

Free cash flow margin 13.3% 1996

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
19931993-12-31	Operating margin	23.1%	Operating Income: 9991910 Open source Revenue: 43215498 Open source
19941994-12-31	Operating margin	19.9%	Operating Income: 12366264 Open source Revenue: 62153975 Open source
19951995-12-31	Operating margin	11.9%	Operating Income: 8872000 Open source Revenue: 74791815 Open source
19961996-12-31	Operating margin	18%	Operating Income: 17995000 Open source Revenue: 100153086 Open source
19931993-12-31	Net margin	14.8%	Net Income: 6410913 Open source Revenue: 43215498 Open source
19941994-12-31	Net margin	12.1%	Net Income: 7519898 Open source Revenue: 62153975 Open source
19951995-12-31	Net margin	16.6%	Net Income: 12389000 Open source Revenue: 74791815 Open source
19961996-12-31	Net margin	18.1%	Net Income: 18139000 Open source Revenue: 100153086 Open source
19931993-12-31	Free cash flow margin	-8.9%	Revenue: 43215498 Open source Operating Cash Flow: 1090658 Open source Capital Expenditure: 4946251 Open source
19941994-12-31	Free cash flow margin	13.7%	Revenue: 62153975 Open source Operating Cash Flow: 12208788 Open source Capital Expenditure: 3688322 Open source
19951995-12-31	Free cash flow margin	6.5%	Revenue: 74791815 Open source Operating Cash Flow: 10304000 Open source Capital Expenditure: 5448000 Open source
19961996-12-31	Free cash flow margin	13.3%	Revenue: 100153086 Open source Operating Cash Flow: 20667000 Open source Capital Expenditure: 7386000 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD 20.7M 1996

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
19931993-12-31	Operating cash flow	1090658	Operating Cash Flow: 1090658 Open source
19941994-12-31	Operating cash flow	12208788	Operating Cash Flow: 12208788 Open source
19951995-12-31	Operating cash flow	10304000	Operating Cash Flow: 10304000 Open source
19961996-12-31	Operating cash flow	20667000	Operating Cash Flow: 20667000 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD 13.3M 1996

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
19931993-12-31	Free cash flow	-3855593	Operating Cash Flow: 1090658 Open source Capital Expenditure: 4946251 Open source
19941994-12-31	Free cash flow	8520466	Operating Cash Flow: 12208788 Open source Capital Expenditure: 3688322 Open source
19951995-12-31	Free cash flow	4856000	Operating Cash Flow: 10304000 Open source Capital Expenditure: 5448000 Open source
19961996-12-31	Free cash flow	13281000	Operating Cash Flow: 20667000 Open source Capital Expenditure: 7386000 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

Not enough comparable data to show this history.

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
1993-12-31	Liabilities / assets	Not reported	Total Assets: 58113000 Open source
1994-12-31	Liabilities / assets	Not reported	Total Assets: 63342000 Open source
1995-12-31	Liabilities / assets	Not reported	Total Assets: 86238000 Open source
1996-12-31	Liabilities / assets	Not reported	Total Assets: 177233000 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

8.03× 1996

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
19931993-12-31	Current assets / current liabilities	2.84×	Current Assets: 22232000 Open source Current Liabilities: 7823000 Open source
19941994-12-31	Current assets / current liabilities	3.32×	Current Assets: 26385000 Open source Current Liabilities: 7952000 Open source
19951995-12-31	Current assets / current liabilities	2.31×	Current Assets: 33337000 Open source Current Liabilities: 14405000 Open source
19961996-12-31	Current assets / current liabilities	8.03×	Current Assets: 80551000 Open source Current Liabilities: 10032000 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
1993 1993-01-01 – 1993-12-31	USD 6.41 million Exact value Exact value: 6410913 USD 1993-01-01 – 1993-12-31: 6410913 USD Inspect Net Income Open source Share or cite Citation for Net Income · JONES PHARMA INC · 1993-12-31 JONES PHARMA INC (edgar:793613) Net Income: 6410913 USD Concept: fundies:NetIncome Period: 1993-01-01 to 1993-12-31 Values: Latest reported Published: 2026-11-02T23:23:14Z Snapshot: ca0e640291d283e31cd085dc5f031d4808aa3fcec275282fa6d28a8b9cdc6dad Dimensions: Consolidated View: https://fundies.io/companies/edgar/793613/explain?concept=fundies%3ANetIncome&period=1993-12-31&surface=latest&period_type=duration&start=1993-01-01&unit=USD&dimensions= Input fundies:NetIncome: 6410913 USD (1993-01-01 to 1993-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/793613/0000950124-96-000971.txt#2291 The citation records this snapshot. The page link may show a newer release later.	USD 1.09 million Exact value Exact value: 1090658 USD 1993-01-01 – 1993-12-31: 1090658 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · JONES PHARMA INC · 1993-12-31 JONES PHARMA INC (edgar:793613) Operating Cash Flow: 1090658 USD Concept: fundies:OperatingCashFlow Period: 1993-01-01 to 1993-12-31 Values: Latest reported Published: 2026-11-02T23:23:14Z Snapshot: ca0e640291d283e31cd085dc5f031d4808aa3fcec275282fa6d28a8b9cdc6dad Dimensions: Consolidated View: https://fundies.io/companies/edgar/793613/explain?concept=fundies%3AOperatingCashFlow&period=1993-12-31&surface=latest&period_type=duration&start=1993-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 1090658 USD (1993-01-01 to 1993-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/793613/0000950124-96-000971.txt#2308 The citation records this snapshot. The page link may show a newer release later.	USD 4.95 million Exact value Exact value: 4946251 USD 1993-01-01 – 1993-12-31: 4946251 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · JONES PHARMA INC · 1993-12-31 JONES PHARMA INC (edgar:793613) Capital Expenditure: 4946251 USD Concept: fundies:CapitalExpenditure Period: 1993-01-01 to 1993-12-31 Values: Latest reported Published: 2026-11-02T23:23:14Z Snapshot: ca0e640291d283e31cd085dc5f031d4808aa3fcec275282fa6d28a8b9cdc6dad Dimensions: Consolidated View: https://fundies.io/companies/edgar/793613/explain?concept=fundies%3ACapitalExpenditure&period=1993-12-31&surface=latest&period_type=duration&start=1993-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 4946251 USD (1993-01-01 to 1993-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/793613/0000950124-96-000971.txt#2314 The citation records this snapshot. The page link may show a newer release later.	−USD 3.86 million Calculation and evidence 1090658 − 4946251 USD Exact free cash flow: -3855593 USD 1993-01-01 – 1993-12-31: 1090658 USD · Inspect Operating Cash Flow · Source 1993-01-01 – 1993-12-31: 4946251 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · JONES PHARMA INC · 1993-12-31 JONES PHARMA INC (edgar:793613) Free cash flow: -3855593 USD Concept: free-cash-flow Period: 1993-01-01 to 1993-12-31 Values: Latest reported Published: 2026-11-02T23:23:14Z Snapshot: ca0e640291d283e31cd085dc5f031d4808aa3fcec275282fa6d28a8b9cdc6dad Dimensions: Consolidated View: https://fundies.io/companies/edgar/793613?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 1090658 USD (1993-01-01 to 1993-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/793613/0000950124-96-000971.txt#2308 Input fundies:CapitalExpenditure: 4946251 USD (1993-01-01 to 1993-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/793613/0000950124-96-000971.txt#2314 The citation records this snapshot. The page link may show a newer release later.
1994 1994-01-01 – 1994-12-31	USD 7.52 million Exact value Exact value: 7519898 USD 1994-01-01 – 1994-12-31: 7519898 USD Inspect Net Income Open source Share or cite Citation for Net Income · JONES PHARMA INC · 1994-12-31 JONES PHARMA INC (edgar:793613) Net Income: 7519898 USD Concept: fundies:NetIncome Period: 1994-01-01 to 1994-12-31 Values: Latest reported Published: 2026-11-02T23:23:14Z Snapshot: ca0e640291d283e31cd085dc5f031d4808aa3fcec275282fa6d28a8b9cdc6dad Dimensions: Consolidated View: https://fundies.io/companies/edgar/793613/explain?concept=fundies%3ANetIncome&period=1994-12-31&surface=latest&period_type=duration&start=1994-01-01&unit=USD&dimensions= Input fundies:NetIncome: 7519898 USD (1994-01-01 to 1994-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/793613/0000950124-97-001477.txt#3012 The citation records this snapshot. The page link may show a newer release later.	USD 12.21 million Exact value Exact value: 12208788 USD 1994-01-01 – 1994-12-31: 12208788 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · JONES PHARMA INC · 1994-12-31 JONES PHARMA INC (edgar:793613) Operating Cash Flow: 12208788 USD Concept: fundies:OperatingCashFlow Period: 1994-01-01 to 1994-12-31 Values: Latest reported Published: 2026-11-02T23:23:14Z Snapshot: ca0e640291d283e31cd085dc5f031d4808aa3fcec275282fa6d28a8b9cdc6dad Dimensions: Consolidated View: https://fundies.io/companies/edgar/793613/explain?concept=fundies%3AOperatingCashFlow&period=1994-12-31&surface=latest&period_type=duration&start=1994-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 12208788 USD (1994-01-01 to 1994-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/793613/0000950124-97-001477.txt#3031 The citation records this snapshot. The page link may show a newer release later.	USD 3.69 million Exact value Exact value: 3688322 USD 1994-01-01 – 1994-12-31: 3688322 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · JONES PHARMA INC · 1994-12-31 JONES PHARMA INC (edgar:793613) Capital Expenditure: 3688322 USD Concept: fundies:CapitalExpenditure Period: 1994-01-01 to 1994-12-31 Values: Latest reported Published: 2026-11-02T23:23:14Z Snapshot: ca0e640291d283e31cd085dc5f031d4808aa3fcec275282fa6d28a8b9cdc6dad Dimensions: Consolidated View: https://fundies.io/companies/edgar/793613/explain?concept=fundies%3ACapitalExpenditure&period=1994-12-31&surface=latest&period_type=duration&start=1994-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 3688322 USD (1994-01-01 to 1994-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/793613/0000950124-97-001477.txt#3037 The citation records this snapshot. The page link may show a newer release later.	USD 8.52 million Calculation and evidence 12208788 − 3688322 USD Exact free cash flow: 8520466 USD 1994-01-01 – 1994-12-31: 12208788 USD · Inspect Operating Cash Flow · Source 1994-01-01 – 1994-12-31: 3688322 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · JONES PHARMA INC · 1994-12-31 JONES PHARMA INC (edgar:793613) Free cash flow: 8520466 USD Concept: free-cash-flow Period: 1994-01-01 to 1994-12-31 Values: Latest reported Published: 2026-11-02T23:23:14Z Snapshot: ca0e640291d283e31cd085dc5f031d4808aa3fcec275282fa6d28a8b9cdc6dad Dimensions: Consolidated View: https://fundies.io/companies/edgar/793613?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 12208788 USD (1994-01-01 to 1994-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/793613/0000950124-97-001477.txt#3031 Input fundies:CapitalExpenditure: 3688322 USD (1994-01-01 to 1994-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/793613/0000950124-97-001477.txt#3037 The citation records this snapshot. The page link may show a newer release later.
1995 1995-01-01 – 1995-12-31	USD 12.39 million Exact value Exact value: 12389000 USD 1995-01-01 – 1995-12-31: 12389000 USD Inspect Net Income Open source Share or cite Citation for Net Income · JONES PHARMA INC · 1995-12-31 JONES PHARMA INC (edgar:793613) Net Income: 12389000 USD Concept: fundies:NetIncome Period: 1995-01-01 to 1995-12-31 Values: Latest reported Published: 2026-11-02T23:23:14Z Snapshot: ca0e640291d283e31cd085dc5f031d4808aa3fcec275282fa6d28a8b9cdc6dad Dimensions: Consolidated View: https://fundies.io/companies/edgar/793613/explain?concept=fundies%3ANetIncome&period=1995-12-31&surface=latest&period_type=duration&start=1995-01-01&unit=USD&dimensions= Input fundies:NetIncome: 12389000 USD (1995-01-01 to 1995-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/793613/0000950124-98-001880.txt#2784 The citation records this snapshot. The page link may show a newer release later.	USD 10.3 million Exact value Exact value: 10304000 USD 1995-01-01 – 1995-12-31: 10304000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · JONES PHARMA INC · 1995-12-31 JONES PHARMA INC (edgar:793613) Operating Cash Flow: 10304000 USD Concept: fundies:OperatingCashFlow Period: 1995-01-01 to 1995-12-31 Values: Latest reported Published: 2026-11-02T23:23:14Z Snapshot: ca0e640291d283e31cd085dc5f031d4808aa3fcec275282fa6d28a8b9cdc6dad Dimensions: Consolidated View: https://fundies.io/companies/edgar/793613/explain?concept=fundies%3AOperatingCashFlow&period=1995-12-31&surface=latest&period_type=duration&start=1995-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 10304000 USD (1995-01-01 to 1995-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/793613/0000950124-98-001880.txt#2804 The citation records this snapshot. The page link may show a newer release later.	USD 5.45 million Exact value Exact value: 5448000 USD 1995-01-01 – 1995-12-31: 5448000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · JONES PHARMA INC · 1995-12-31 JONES PHARMA INC (edgar:793613) Capital Expenditure: 5448000 USD Concept: fundies:CapitalExpenditure Period: 1995-01-01 to 1995-12-31 Values: Latest reported Published: 2026-11-02T23:23:14Z Snapshot: ca0e640291d283e31cd085dc5f031d4808aa3fcec275282fa6d28a8b9cdc6dad Dimensions: Consolidated View: https://fundies.io/companies/edgar/793613/explain?concept=fundies%3ACapitalExpenditure&period=1995-12-31&surface=latest&period_type=duration&start=1995-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 5448000 USD (1995-01-01 to 1995-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/793613/0000950124-98-001880.txt#2807 The citation records this snapshot. The page link may show a newer release later.	USD 4.86 million Calculation and evidence 10304000 − 5448000 USD Exact free cash flow: 4856000 USD 1995-01-01 – 1995-12-31: 10304000 USD · Inspect Operating Cash Flow · Source 1995-01-01 – 1995-12-31: 5448000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · JONES PHARMA INC · 1995-12-31 JONES PHARMA INC (edgar:793613) Free cash flow: 4856000 USD Concept: free-cash-flow Period: 1995-01-01 to 1995-12-31 Values: Latest reported Published: 2026-11-02T23:23:14Z Snapshot: ca0e640291d283e31cd085dc5f031d4808aa3fcec275282fa6d28a8b9cdc6dad Dimensions: Consolidated View: https://fundies.io/companies/edgar/793613?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 10304000 USD (1995-01-01 to 1995-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/793613/0000950124-98-001880.txt#2804 Input fundies:CapitalExpenditure: 5448000 USD (1995-01-01 to 1995-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/793613/0000950124-98-001880.txt#2807 The citation records this snapshot. The page link may show a newer release later.
1996 1996-01-01 – 1996-12-31	USD 18.14 million Exact value Exact value: 18139000 USD 1996-01-01 – 1996-12-31: 18139000 USD Inspect Net Income Open source Share or cite Citation for Net Income · JONES PHARMA INC · 1996-12-31 JONES PHARMA INC (edgar:793613) Net Income: 18139000 USD Concept: fundies:NetIncome Period: 1996-01-01 to 1996-12-31 Values: Latest reported Published: 2026-11-02T23:23:14Z Snapshot: ca0e640291d283e31cd085dc5f031d4808aa3fcec275282fa6d28a8b9cdc6dad Dimensions: Consolidated View: https://fundies.io/companies/edgar/793613/explain?concept=fundies%3ANetIncome&period=1996-12-31&surface=latest&period_type=duration&start=1996-01-01&unit=USD&dimensions= Input fundies:NetIncome: 18139000 USD (1996-01-01 to 1996-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/793613/0000950124-99-002271.txt#2964 The citation records this snapshot. The page link may show a newer release later.	USD 20.67 million Exact value Exact value: 20667000 USD 1996-01-01 – 1996-12-31: 20667000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · JONES PHARMA INC · 1996-12-31 JONES PHARMA INC (edgar:793613) Operating Cash Flow: 20667000 USD Concept: fundies:OperatingCashFlow Period: 1996-01-01 to 1996-12-31 Values: Latest reported Published: 2026-11-02T23:23:14Z Snapshot: ca0e640291d283e31cd085dc5f031d4808aa3fcec275282fa6d28a8b9cdc6dad Dimensions: Consolidated View: https://fundies.io/companies/edgar/793613/explain?concept=fundies%3AOperatingCashFlow&period=1996-12-31&surface=latest&period_type=duration&start=1996-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 20667000 USD (1996-01-01 to 1996-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/793613/0000950124-99-002271.txt#2989 The citation records this snapshot. The page link may show a newer release later.	USD 7.39 million Exact value Exact value: 7386000 USD 1996-01-01 – 1996-12-31: 7386000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · JONES PHARMA INC · 1996-12-31 JONES PHARMA INC (edgar:793613) Capital Expenditure: 7386000 USD Concept: fundies:CapitalExpenditure Period: 1996-01-01 to 1996-12-31 Values: Latest reported Published: 2026-11-02T23:23:14Z Snapshot: ca0e640291d283e31cd085dc5f031d4808aa3fcec275282fa6d28a8b9cdc6dad Dimensions: Consolidated View: https://fundies.io/companies/edgar/793613/explain?concept=fundies%3ACapitalExpenditure&period=1996-12-31&surface=latest&period_type=duration&start=1996-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 7386000 USD (1996-01-01 to 1996-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/793613/0000950124-99-002271.txt#2993 The citation records this snapshot. The page link may show a newer release later.	USD 13.28 million Calculation and evidence 20667000 − 7386000 USD Exact free cash flow: 13281000 USD 1996-01-01 – 1996-12-31: 20667000 USD · Inspect Operating Cash Flow · Source 1996-01-01 – 1996-12-31: 7386000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · JONES PHARMA INC · 1996-12-31 JONES PHARMA INC (edgar:793613) Free cash flow: 13281000 USD Concept: free-cash-flow Period: 1996-01-01 to 1996-12-31 Values: Latest reported Published: 2026-11-02T23:23:14Z Snapshot: ca0e640291d283e31cd085dc5f031d4808aa3fcec275282fa6d28a8b9cdc6dad Dimensions: Consolidated View: https://fundies.io/companies/edgar/793613?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 20667000 USD (1996-01-01 to 1996-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/793613/0000950124-99-002271.txt#2989 Input fundies:CapitalExpenditure: 7386000 USD (1996-01-01 to 1996-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/793613/0000950124-99-002271.txt#2993 The citation records this snapshot. The page link may show a newer release later.
1997 1997-01-01 – 1997-12-31	USD 31.97 million Exact value Exact value: 31970000 USD 1997-01-01 – 1997-12-31: 31970000 USD Inspect Net Income Open source Share or cite Citation for Net Income · JONES PHARMA INC · 1997-12-31 JONES PHARMA INC (edgar:793613) Net Income: 31970000 USD Concept: fundies:NetIncome Period: 1997-01-01 to 1997-12-31 Values: Latest reported Published: 2026-11-02T23:23:14Z Snapshot: ca0e640291d283e31cd085dc5f031d4808aa3fcec275282fa6d28a8b9cdc6dad Dimensions: Consolidated View: https://fundies.io/companies/edgar/793613/explain?concept=fundies%3ANetIncome&period=1997-12-31&surface=latest&period_type=duration&start=1997-01-01&unit=USD&dimensions= Input fundies:NetIncome: 31970000 USD (1997-01-01 to 1997-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/793613/0000950124-00-001305.txt#2913 The citation records this snapshot. The page link may show a newer release later.	USD 31.72 million Exact value Exact value: 31718000 USD 1997-01-01 – 1997-12-31: 31718000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · JONES PHARMA INC · 1997-12-31 JONES PHARMA INC (edgar:793613) Operating Cash Flow: 31718000 USD Concept: fundies:OperatingCashFlow Period: 1997-01-01 to 1997-12-31 Values: Latest reported Published: 2026-11-02T23:23:14Z Snapshot: ca0e640291d283e31cd085dc5f031d4808aa3fcec275282fa6d28a8b9cdc6dad Dimensions: Consolidated View: https://fundies.io/companies/edgar/793613/explain?concept=fundies%3AOperatingCashFlow&period=1997-12-31&surface=latest&period_type=duration&start=1997-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 31718000 USD (1997-01-01 to 1997-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/793613/0000950124-00-001305.txt#2934 The citation records this snapshot. The page link may show a newer release later.	USD 5.57 million Exact value Exact value: 5566000 USD 1997-01-01 – 1997-12-31: 5566000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · JONES PHARMA INC · 1997-12-31 JONES PHARMA INC (edgar:793613) Capital Expenditure: 5566000 USD Concept: fundies:CapitalExpenditure Period: 1997-01-01 to 1997-12-31 Values: Latest reported Published: 2026-11-02T23:23:14Z Snapshot: ca0e640291d283e31cd085dc5f031d4808aa3fcec275282fa6d28a8b9cdc6dad Dimensions: Consolidated View: https://fundies.io/companies/edgar/793613/explain?concept=fundies%3ACapitalExpenditure&period=1997-12-31&surface=latest&period_type=duration&start=1997-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 5566000 USD (1997-01-01 to 1997-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/793613/0000950124-00-001305.txt#2938 The citation records this snapshot. The page link may show a newer release later.	USD 26.15 million Calculation and evidence 31718000 − 5566000 USD Exact free cash flow: 26152000 USD 1997-01-01 – 1997-12-31: 31718000 USD · Inspect Operating Cash Flow · Source 1997-01-01 – 1997-12-31: 5566000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · JONES PHARMA INC · 1997-12-31 JONES PHARMA INC (edgar:793613) Free cash flow: 26152000 USD Concept: free-cash-flow Period: 1997-01-01 to 1997-12-31 Values: Latest reported Published: 2026-11-02T23:23:14Z Snapshot: ca0e640291d283e31cd085dc5f031d4808aa3fcec275282fa6d28a8b9cdc6dad Dimensions: Consolidated View: https://fundies.io/companies/edgar/793613?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 31718000 USD (1997-01-01 to 1997-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/793613/0000950124-00-001305.txt#2934 Input fundies:CapitalExpenditure: 5566000 USD (1997-01-01 to 1997-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/793613/0000950124-00-001305.txt#2938 The citation records this snapshot. The page link may show a newer release later.
1998 1998-01-01 – 1998-12-31	USD 42.34 million Exact value Exact value: 42335000 USD 1998-01-01 – 1998-12-31: 42335000 USD Inspect Net Income Open source Share or cite Citation for Net Income · JONES PHARMA INC · 1998-12-31 JONES PHARMA INC (edgar:793613) Net Income: 42335000 USD Concept: fundies:NetIncome Period: 1998-01-01 to 1998-12-31 Values: Latest reported Published: 2026-11-02T23:23:14Z Snapshot: ca0e640291d283e31cd085dc5f031d4808aa3fcec275282fa6d28a8b9cdc6dad Dimensions: Consolidated View: https://fundies.io/companies/edgar/793613/explain?concept=fundies%3ANetIncome&period=1998-12-31&surface=latest&period_type=duration&start=1998-01-01&unit=USD&dimensions= Input fundies:NetIncome: 42335000 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/793613/0000950124-00-001305.txt#2913 The citation records this snapshot. The page link may show a newer release later.	USD 21.94 million Exact value Exact value: 21942000 USD 1998-01-01 – 1998-12-31: 21942000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · JONES PHARMA INC · 1998-12-31 JONES PHARMA INC (edgar:793613) Operating Cash Flow: 21942000 USD Concept: fundies:OperatingCashFlow Period: 1998-01-01 to 1998-12-31 Values: Latest reported Published: 2026-11-02T23:23:14Z Snapshot: ca0e640291d283e31cd085dc5f031d4808aa3fcec275282fa6d28a8b9cdc6dad Dimensions: Consolidated View: https://fundies.io/companies/edgar/793613/explain?concept=fundies%3AOperatingCashFlow&period=1998-12-31&surface=latest&period_type=duration&start=1998-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 21942000 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/793613/0000950124-00-001305.txt#2934 The citation records this snapshot. The page link may show a newer release later.	USD 2.33 million Exact value Exact value: 2333000 USD 1998-01-01 – 1998-12-31: 2333000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · JONES PHARMA INC · 1998-12-31 JONES PHARMA INC (edgar:793613) Capital Expenditure: 2333000 USD Concept: fundies:CapitalExpenditure Period: 1998-01-01 to 1998-12-31 Values: Latest reported Published: 2026-11-02T23:23:14Z Snapshot: ca0e640291d283e31cd085dc5f031d4808aa3fcec275282fa6d28a8b9cdc6dad Dimensions: Consolidated View: https://fundies.io/companies/edgar/793613/explain?concept=fundies%3ACapitalExpenditure&period=1998-12-31&surface=latest&period_type=duration&start=1998-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 2333000 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/793613/0000950124-00-001305.txt#2938 The citation records this snapshot. The page link may show a newer release later.	USD 19.61 million Calculation and evidence 21942000 − 2333000 USD Exact free cash flow: 19609000 USD 1998-01-01 – 1998-12-31: 21942000 USD · Inspect Operating Cash Flow · Source 1998-01-01 – 1998-12-31: 2333000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · JONES PHARMA INC · 1998-12-31 JONES PHARMA INC (edgar:793613) Free cash flow: 19609000 USD Concept: free-cash-flow Period: 1998-01-01 to 1998-12-31 Values: Latest reported Published: 2026-11-02T23:23:14Z Snapshot: ca0e640291d283e31cd085dc5f031d4808aa3fcec275282fa6d28a8b9cdc6dad Dimensions: Consolidated View: https://fundies.io/companies/edgar/793613?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 21942000 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/793613/0000950124-00-001305.txt#2934 Input fundies:CapitalExpenditure: 2333000 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/793613/0000950124-00-001305.txt#2938 The citation records this snapshot. The page link may show a newer release later.
1999 1999-01-01 – 1999-12-31	USD 48.94 million Exact value Exact value: 48944000 USD 1999-01-01 – 1999-12-31: 48944000 USD Inspect Net Income Open source Share or cite Citation for Net Income · JONES PHARMA INC · 1999-12-31 JONES PHARMA INC (edgar:793613) Net Income: 48944000 USD Concept: fundies:NetIncome Period: 1999-01-01 to 1999-12-31 Values: Latest reported Published: 2026-11-02T23:23:14Z Snapshot: ca0e640291d283e31cd085dc5f031d4808aa3fcec275282fa6d28a8b9cdc6dad Dimensions: Consolidated View: https://fundies.io/companies/edgar/793613/explain?concept=fundies%3ANetIncome&period=1999-12-31&surface=latest&period_type=duration&start=1999-01-01&unit=USD&dimensions= Input fundies:NetIncome: 48944000 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/793613/0000950124-00-001305.txt#2913 The citation records this snapshot. The page link may show a newer release later.	USD 58.1 million Exact value Exact value: 58097000 USD 1999-01-01 – 1999-12-31: 58097000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · JONES PHARMA INC · 1999-12-31 JONES PHARMA INC (edgar:793613) Operating Cash Flow: 58097000 USD Concept: fundies:OperatingCashFlow Period: 1999-01-01 to 1999-12-31 Values: Latest reported Published: 2026-11-02T23:23:14Z Snapshot: ca0e640291d283e31cd085dc5f031d4808aa3fcec275282fa6d28a8b9cdc6dad Dimensions: Consolidated View: https://fundies.io/companies/edgar/793613/explain?concept=fundies%3AOperatingCashFlow&period=1999-12-31&surface=latest&period_type=duration&start=1999-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 58097000 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/793613/0000950124-00-001305.txt#2934 The citation records this snapshot. The page link may show a newer release later.	USD 4.05 million Exact value Exact value: 4049000 USD 1999-01-01 – 1999-12-31: 4049000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · JONES PHARMA INC · 1999-12-31 JONES PHARMA INC (edgar:793613) Capital Expenditure: 4049000 USD Concept: fundies:CapitalExpenditure Period: 1999-01-01 to 1999-12-31 Values: Latest reported Published: 2026-11-02T23:23:14Z Snapshot: ca0e640291d283e31cd085dc5f031d4808aa3fcec275282fa6d28a8b9cdc6dad Dimensions: Consolidated View: https://fundies.io/companies/edgar/793613/explain?concept=fundies%3ACapitalExpenditure&period=1999-12-31&surface=latest&period_type=duration&start=1999-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 4049000 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/793613/0000950124-00-001305.txt#2938 The citation records this snapshot. The page link may show a newer release later.	USD 54.05 million Calculation and evidence 58097000 − 4049000 USD Exact free cash flow: 54048000 USD 1999-01-01 – 1999-12-31: 58097000 USD · Inspect Operating Cash Flow · Source 1999-01-01 – 1999-12-31: 4049000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · JONES PHARMA INC · 1999-12-31 JONES PHARMA INC (edgar:793613) Free cash flow: 54048000 USD Concept: free-cash-flow Period: 1999-01-01 to 1999-12-31 Values: Latest reported Published: 2026-11-02T23:23:14Z Snapshot: ca0e640291d283e31cd085dc5f031d4808aa3fcec275282fa6d28a8b9cdc6dad Dimensions: Consolidated View: https://fundies.io/companies/edgar/793613?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 58097000 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/793613/0000950124-00-001305.txt#2934 Input fundies:CapitalExpenditure: 4049000 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/793613/0000950124-00-001305.txt#2938 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

25 filings · 0 latest values · 0 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0000793613, 793613, edgar:793613

Also known as JONES MEDICAL INDUSTRIES INC /DE/

JONES PHARMA INC

Latest quarter

Revenue

Operating margin

Operating cash flow

Free cash flow

Trailing twelve months

Net income

Operating cash flow

Capital expenditure

Free cash flow

Company performance

What changed year over year

Net income

Operating cash flow

Capital expenditure

Where revenue goes

1996 1996-01-01 – 1996-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation